New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
PatentVest has released a comprehensive report titled "The Next Era of Surgical Robotics" analyzing the $188B surgical robotics market. The report, based on analysis of 18,000+ patent families and $4B in M&A activity, reveals that despite 310 million annual global surgeries, only 6% involve robots.
The study examines 28 robotic platforms and identifies key market players, including Intuitive Surgical as the dominant patent holder, legacy incumbents like Medtronic and Johnson & Johnson, and emerging challengers such as Vicarious Surgical and CMR Surgical. The report highlights how venture-backed platforms are positioning themselves for strategic scale, following the path of successful acquisitions like MAKO, Auris, and Mazor.
PatentVest ha pubblicato un rapporto completo intitolato "La nuova era della robotica chirurgica" che analizza il mercato della robotica chirurgica da 188 miliardi di dollari. Il rapporto, basato sull'analisi di oltre 18.000 famiglie di brevetti e 4 miliardi di dollari in attivit脿 di fusioni e acquisizioni, rivela che, nonostante 310 milioni di interventi chirurgici globali all'anno, solo il 6% coinvolge robot.
Lo studio esamina 28 piattaforme robotiche e individua i principali attori del mercato, tra cui Intuitive Surgical come principale detentore di brevetti, i colossi storici come Medtronic e Johnson & Johnson, e i nuovi sfidanti emergenti come Vicarious Surgical e CMR Surgical. Il rapporto evidenzia come le piattaforme supportate da venture capital si stiano posizionando per una crescita strategica, seguendo la strada di acquisizioni di successo come MAKO, Auris e Mazor.
PatentVest ha publicado un informe completo titulado "La pr贸xima era de la rob贸tica quir煤rgica" que analiza el mercado de rob贸tica quir煤rgica de 188 mil millones de d贸lares. El informe, basado en el an谩lisis de m谩s de 18,000 familias de patentes y 4 mil millones de d贸lares en actividades de fusiones y adquisiciones, revela que, a pesar de 310 millones de cirug铆as globales anuales, solo el 6% involucra robots.
El estudio examina 28 plataformas rob贸ticas e identifica a los principales actores del mercado, incluyendo a Intuitive Surgical como el principal titular de patentes, a los incumbentes tradicionales como Medtronic y Johnson & Johnson, y a los nuevos desafiantes emergentes como Vicarious Surgical y CMR Surgical. El informe destaca c贸mo las plataformas respaldadas por capital de riesgo se est谩n posicionando para una escala estrat茅gica, siguiendo el camino de adquisiciones exitosas como MAKO, Auris y Mazor.
PatentVest电� 1880鞏� 雼煬 攴滊鞚� 靾橃垹鞖� 搿滊磭 鞁滌灔鞚� 攵勳劃頃� "靾橃垹鞖� 搿滊磭鞚� 雼れ潓 鞁滊寑"霛嫉鐢 膦呿暕 氤搓碃靹滊ゼ 氚滍憸頄堨姷雼堧嫟. 鞚� 氤搓碃靹湹鐢 18,000臧� 鞚挫儊鞚� 韸鬼棃甑�瓿� 40鞏� 雼煬鞚� 鞚胳垬頃╇硲 頇滊彊鞚� 旮半皹鞙茧 頃橂┌, 鞝� 靹戈硠 鞐瓣皠 3鞏� 1觳滊 瓯挫潣 靾橃垹 欷� 雼 6%毵岇澊 搿滊磭鞚� 頇滌毄頃滊嫟电� 靷嫟鞚� 氚濏様鞀惦媹雼�.
鞐瓣惮电� 28臧滌潣 搿滊磭 頂岆灚韽检潉 臁办偓頃橁碃, 欤检殧 鞁滌灔 頂岆爤鞚挫柎搿� Intuitive Surgical鞚� 歆�氚办爜 韸鬼棃 氤挫湢鞛愲, 旮办〈 雽�旮办梾鞚� Medtronic瓿� Johnson & Johnson, 攴鸽Μ瓿� 鞁犿潵 霃勳爠鞛� Vicarious Surgical瓿� CMR Surgical鞚� 鞁濍硠頄堨姷雼堧嫟. 氤搓碃靹湹鐢 氩れ矘 鞛愱笀 歆�鞗� 頂岆灚韽茧摛鞚� MAKO, Auris, Mazor鞕� 臧欖潃 靹标车鞝侅澑 鞚胳垬 靷毳� 霐半澕 鞝勲灥鞝� 頇曥灔鞚� 鞙勴暣 鞛愲Μ毵り箑頃橁碃 鞛堨潓鞚� 臧曥“頃╇媹雼�.
PatentVest a publi茅 un rapport complet intitul茅 "La prochaine 猫re de la robotique chirurgicale" analysant le march茅 de la robotique chirurgicale de 188 milliards de dollars. Ce rapport, bas茅 sur l'analyse de plus de 18 000 familles de brevets et 4 milliards de dollars d'activit茅s de fusions-acquisitions, r茅v猫le que malgr茅 310 millions d'interventions chirurgicales annuelles dans le monde, seuls 6 % impliquent des robots.
L'茅tude examine 28 plateformes robotiques et identifie les acteurs cl茅s du march茅, notamment Intuitive Surgical en tant que d茅tenteur dominant de brevets, les acteurs historiques comme Medtronic et Johnson & Johnson, ainsi que les nouveaux challengers 茅mergents tels que Vicarious Surgical et CMR Surgical. Le rapport souligne comment les plateformes soutenues par des fonds de capital-risque se positionnent pour une croissance strat茅gique, suivant la voie d'acquisitions r茅ussies telles que MAKO, Auris et Mazor.
PatentVest hat einen umfassenden Bericht mit dem Titel "Die n盲chste 脛ra der chirurgischen Robotik" ver枚ffentlicht, der den 188-Milliarden-Dollar-Markt f眉r chirurgische Robotik analysiert. Der Bericht basiert auf der Analyse von 眉ber 18.000 Patentfamilien und 4 Milliarden Dollar an M&A-Aktivit盲ten und zeigt, dass trotz 310 Millionen globaler Operationen pro Jahr nur 6 % davon Roboter einsetzen.
Die Studie untersucht 28 robotische Plattformen und identifiziert wichtige Marktteilnehmer, darunter Intuitive Surgical als dominierenden Patentinhaber, etablierte Unternehmen wie Medtronic und Johnson & Johnson sowie aufstrebende Herausforderer wie Vicarious Surgical und CMR Surgical. Der Bericht hebt hervor, wie von Risikokapital unterst眉tzte Plattformen sich strategisch positionieren, um zu wachsen, und dabei dem Weg erfolgreicher 脺bernahmen wie MAKO, Auris und Mazor folgen.
- Market opportunity is significant with only 6% robotic surgery penetration out of 310 million annual surgeries
- Analysis covers extensive data: 18,000+ patent families and $4B in M&A activity
- Multiple emerging players and venture-backed platforms showing strong potential for M&A or market leadership
- Market growth has remained flat due to cost, complexity, and deployment constraints
- Intuitive Surgical's dominance is showing signs of slowing down in new patent filings
Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who鈥檚 actually leading and why in one of the most underpenetrated markets in medtech
DALLAS, TX , July 10, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP strategy and legal firm, today announced the release of a new report that maps the most important shift in medtech since the rise of the da Vinci system. Built from analysis of more than 18,000 patent families,
The findings challenge the assumption that surgical robotics is a saturated category. Despite more than 310 million surgeries performed globally each year, fewer than
The report identifies the strategic signals that define tomorrow鈥檚 category leaders. These include IP positioning, regulatory momentum, and platform scalability. It also highlights which companies are most likely to be acquired or emerge as the next market leaders.
Key Findings From PatentVest
- Intuitive remains dominant, but no longer expanding as fast: Intuitive Surgical still holds the largest IP portfolio but recent momentum has shifted, with multiple challengers outpacing it in new filings over the past decade.
- Legacy incumbents anchor the commercial infrastructure: Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker, and Smith+Nephew maintain strong commercial footprints and regulatory muscle.
- Public challengers are gaining traction: Companies like Vicarious Surgical, Microbot Medical, Stereotaxis, SS Innovations, and Meere Company are advancing platforms across endovascular, dental, and NOTES applications - with focused IP portfolios and early-stage clinical validation.
- Venture-backed platforms are increasingly aligning for strategic scale: Private companies such as CMR Surgical, THINK Surgical, Distalmotion, EndoQuest Robotics, Neocis, Virtual Incision, and ForSight Robotics are aligning capital, regulatory milestones, and broad IP positions - closely mirroring the profile of past M&A targets like MAKO, Auris, and Mazor.
鈥淓very major surgical robotics platform, including Mako, Monarch, and Hugo, started as a venture-backed company with focused IP and regulatory momentum. This report identifies who鈥檚 next. Somewhere in this cohort is the next Intuitive Surgical, or the company that gets acquired before it becomes one,鈥� said Will Rosellini, Chief IP Officer at PatentVest.
Access the Full Report
The latest PatentVest Pulse report is now live. Explore the data, insights, and strategic signals behind the 28 companies redefining the future of surgical robotics.
For more information or inquiries, please contact聽.
About PatentVest
PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and expert analysis, PatentVest delivers actionable insights that help clients navigate complex IP landscapes and stay ahead of the curve. This report is powered by PatentVest鈥檚 proprietary IP intelligence platform.
FAQ
What is the current market penetration of surgical robotics according to PatentVest's report?
Who are the main competitors in the surgical robotics market as identified by PatentVest?
What is the size of the surgical robotics market analyzed in the PatentVest report?
How many patent families and M&A activity did the PatentVest report analyze?
Which companies are identified as potential acquisition targets in the surgical robotics space?
